Counseling Patients about Hormones and Alternatives for Menopausal Symptoms
Abstract
Menopause typically begins in the early fifties, although the exact age of menopause will vary from woman to woman. There are several symptoms associated with menopause that can be bothersome, and prompt women to seek treatment from their primary care provider. The purpose of this review is to describe the currently available therapies, as well as the evidence that provides support for their use. The most effective therapy for menopause symptoms is hormone therapy (HT); however, while effective for menopausal symptom relief there are several potential risks to consider prior to initiating HT. Some evidence suggests that HT can increase the risk of certain types of cancers and should be avoided in women who are at high risk for ovarian cancer or breast cancer. Non-hormonal conventional therapies include selective serotonin reuptake inhibitors (SSRIs), clonidine and gabapentin. Bioidentical hormone therapy has also been shown to be effective in the relief of symptoms, but requires further research to elucidate the potential risks associated with it. Complementary and alternative (CAM) therapies include phytoestrogen, botanical and herbal treatments, acupuncture, osteopathic manipulation therapy and behavioral interventions.
References
National Institutes of, H., National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med, 2005. 142(12 Pt 1): p. 1003-13.
Wong, V.C., et al., Current alternative and complementary therapies used in menopause. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2009. 25(3): p. 166-74.
Administration, U.S.F.a.D., Estrogen and Estrogen with Progestin Therapies for Postmenopausal Women. Food and Drug Administration, 2010.
Anderson, G.L., et al., Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA, 2004. 291(14): p. 1701-12.
Rossouw, J.E., et al., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA, 2002. 288(3): p. 321-33.
Stefanick, M.L., et al., Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA, 2006. 295(14): p. 1647-57.
Ravdin, P.M., et al., The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med, 2007. 356(16): p. 1670-4.
Fournier, A., et al., Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks? J Clin Oncol, 2009. 27(31): p. 5138-43.
Lyytinen, H., E. Pukkala, and O. Ylikorkala, Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstet Gynecol, 2009. 113(1): p. 65-73.
Lindsay, R., et al., Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril, 2009. 92(3): p. 1045-52.
Archer, D.F., et al., Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women. Fertil Steril, 2009. 92(3): p. 1039-44.
Lobo, R.A., et al., Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile. Fertil Steril, 2009. 92(3): p. 1025-38.
Anderson, G.L., et al., Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA, 2003. 290(13): p. 1739-48.
Chlebowski, R.T., et al., Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet, 2009. 374(9697): p. 1243-51.
Manson, J.E., et al., Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med, 2003. 349(6): p. 523-34.
Manson, J.E., et al., Estrogen therapy and coronary-artery calcification. N Engl J Med, 2007. 356(25): p. 2591-602.
Rossouw, J.E., et al., Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA, 2007. 297(13): p. 1465-77.
Salpeter, S.R., et al., Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. Am J Med, 2009. 122(11): p. 1016-1022 e1.
Harman, S.M., et al., KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric, 2005. 8(1): p. 3-12.
Cirigliano, M., Bioidentical hormone therapy: a review of the evidence. J Womens Health (Larchmt), 2007. 16(5): p. 600-31.
Boothby, L.A., P.L. Doering, and S. Kipersztok, Bioidentical hormone therapy: a review. Menopause, 2004. 11(3): p. 356-67.
Conaway, E., Bioidentical hormones: an evidence-based review for primary care providers. J Am Osteopath Assoc, 2011. 111(3): p. 153-64.
Fournier, A., F. Berrino, and F. Clavel-Chapelon, Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat, 2008. 107(1): p. 103-11.
Sood, R., et al., Counseling postmenopausal women about bioidentical hormones: ten discussion points for practicing physicians. J Am Board Fam Med, 2011. 24(2): p. 202-10.
Nedrow, A., et al., Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med, 2006. 166(14): p. 1453-65.
McBane, S.E., Easing vasomotor symptoms: Besides HRT, what works? JAAPA, 2008. 21(4): p. 26-31.
Nelson, H.D., et al., Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA, 2006. 295(17): p. 2057-71.
MacGregor CA, C.P., Patterson G et al., A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer, 2005. 41: p. 708-714.
Krebs, E.E., et al., Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol, 2004. 104(4): p. 824-36.
Rowland, I.R., et al., Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr Cancer, 2000. 36(1): p. 27-32.
Geller, S.E. and L. Studee, Contemporary alternatives to plant estrogens for menopause. Maturitas, 2006. 55 Suppl 1: p. S3-13.
Low Dog, T., K.L. Powell, and S.M. Weisman, Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause, 2003. 10(4): p. 299-313.
Burdette, J.E., et al., Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem, 2003. 51(19): p. 5661-70.
Newton, K.M., et al., Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med, 2006. 145(12): p. 869-79.
Borrelli, F. and E. Ernst, Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol Res, 2008. 58(1): p. 8-14.
Fritz, H., et al., Black Cohosh and Breast Cancer: A Systematic Review. Integr Cancer Ther, 2013.
Osmers, R., et al., Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol, 2005. 105(5 Pt 1): p. 1074-83.
Hickey, M., C.M. Saunders, and B.G. Stuckey, Non-hormonal treatments for menopausal symptoms. Maturitas, 2007. 57(1): p. 85-9.
Stearns, V., et al., Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA, 2003. 289(21): p. 2827-34.
Evans, M.L., et al., Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol, 2005. 105(1): p. 161-6.
Stearns, V., et al., Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol, 2005. 23(28): p. 6919-30.
Loprinzi, C.L., et al., Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet, 2000. 356(9247): p. 2059-63.
Weitzner, M.A., et al., A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage, 2002. 23(4): p. 337-45.
Cheema, D., A. Coomarasamy, and T. El-Toukhy, Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet, 2007. 276(5): p. 463-9.
Guttuso, T.J., Jr., Gabapentin's effects on hot flashes and hypothermia. Neurology, 2000. 54(11): p. 2161-3.
Reddy, S.Y., et al., Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol, 2006. 108(1): p. 41-8.
Guttuso, T., Jr., J. Roscoe, and J. Griggs, Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer. Lancet, 2003. 361(9370): p. 1703-5.
Pandya, K.J., et al., Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet, 2005. 366(9488): p. 818-24.
Albertazzi, P., Non-estrogenic approaches for the treatment of climacteric symptoms. Climacteric, 2007. 10 Suppl 2: p. 115-20.
Joshi, S., et al., Effect of yoga on menopausal symptoms. Menopause international, 2011. 17(3): p. 78-81.
Cramer, H., et al., Effectiveness of yoga for menopausal symptoms: a systematic review and meta-analysis of randomized controlled trials. Evidence-based Complementary and Alternative Medicine: eCAM, 2012.
Allen, L.A., et al., Cognitive behavior therapy for menopausal hot flashes: two case reports. Maturitas, 2006. 54(1): p. 95-9.
Towey, M., C. Bundy, and L. Cordingley, Psychological and social interventions in the menopause. Current opinion in obstetrics & gynecology, 2006. 18(4): p. 413-7.
Ganz, P.A., et al., Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. Journal of the National Cancer Institute, 2000. 92(13): p. 1054-64.
Cho, S.H. and W.W. Whang, Acupuncture for vasomotor menopausal symptoms: a systematic review. Menopause, 2009. 16(5): p. 1065-73.
Walker, E.M., et al., Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol, 2010. 28(4): p. 634-40.
Frisk, J., et al., Long-term follow-up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicenter trial. Climacteric, 2008. 11(2): p. 166-74.
Benjamin, B.A., et al., The Autonomic Nervous System Activity and Osteopathic Manipulation. The Journal of the Federation of American Societies for Experimental Biology, 2007. 21: p. 573.
Cleary, C. and J.P. Fox, Menopausal symptoms: an osteopathic investigation. Complementary therapies in medicine, 1994. 2: p. 181-186.
Mueckler, A., Osteopathic treatment during transition of perimenopause. 2005.
Downloads
Published
How to Cite
Issue
Section
License
Accepted 2014-06-25
Published 2014-07-07
